in which they “recommend against routine testing for Factor V Leiden and/or the prothrombin 20210G>A mutation in asymptomatic family members of patients with VTE with Factor V Leiden or ...

[9] Pregnant women with the most common heritable thrombophilias (i.e., heterozygosity for factor V Leiden [OR: 8.3; 95% CI: 5.4–12.7] or the prothrombin G20210A mutation [OR: 6.8; 95% CI ...